Ma.s.Q>- M G ORPEPCTEINVCEIDC STUDY OF MYOCARDIAL INFARCTION AT WASHINGTON WORKS PLANT This study was conducted to evaluate the incidence of cases of myocardial infarction among male wage and salary roll employees at the Washington Works Plant from 1956 to 1973.

ARA6 -- I7JT TSCA NCIC Notification Form for CBI Documents Docket Number: f) 7$ ____________ Document Control Number: Document Date: Document Type: _____________ P________ M CCEZD3 oo mTJ 030 "Orn -o o ro -- i r n 33* 3C o o CO CO sr Th e d o c u m e n t r e f e r e n c e d a b o v e is c la im e d a s c o n fid e n tia l b u s in e s s in fo r m a tio n (CBI) u n d e r Se c t io n 14 o f the To x ic S u b s ta n c e s C o n tro l A c t (TSCA).

"^fe-26- f(,3 7 CENTRAL RESEARCH AND DEVELOPMENT DEPARTMENT HASKELL LABORATORY FOR TOXICOLOGY cc: ANO INDUSTRIAL MEDICINE .a* .V A 0. 3.

RECiiiVEO O P P NC IC 200*4MAY 12 AH 9= 10 -4&224r mo FINAL REPORT PROTOCOL 418-028 ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 FINAL REPORT DATE: 31 JULY 2003 PROTOCOL 418-028 - ORAL (GAVAGE) COMBINED REPEATED DOSE TOXICITY STUDY OF T-7706 WITH THE REPRODUCTION/DEVELOPMENTAL TOXICITY SCREENING TEST SPONSOR'S STUDY NUMBER: T-7706.1 TABLE OF CONTENTS SUBJECT 1.

3M Companv EPI-0016 Page 1 of 30 FINAL REPORT Epidemiology Medical Department 3M Company S t Paul.

STUDY TITLE Extraction of Potassium Perfluorooctanesulfonate from Red Blood Cells and Serum for Analysis Using HPLC-Electrospray/Mass Spectrometry DATA REQUIREMENTS Analytical Method Requirements STUDY DIRECTOR Sean Gallagher ANALYTICAL REPORT DATE June 2, 2003 PERFORMING LABORATORY / TESTING FACILITY Exygen Research 3058 Research Drive State College, PA 16801 Phone: 814-272-1039 STUDY SPONSOR 3M Environmental Technology and Safety Services Building 2-3E-09 PO Box 33331 St.

STUDY TITLE Extraction of Potassium Perfluorooctanesulfonate from Mallard Serum and Mallard Liver for Analysis Using HPLC-Electrospray/Mass Spectrometry DATA REQUIREMENTS Analytical Method Requirements STUDY DIRECTOR Sean Gallagher STUDY COMPLETED ON September 06, 2001 PERFORMING LABORATORY / TESTING FACILITY Centre Analytical Laboratories, Inc.

BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE November 2004 Click on Study Title to View Report November 21, 2004 POSF Perfluorooctanesulfonyl fluoride "Bladder cancer in Perfluorooctanesulfonyl Fluoride Manufacturing Workers," Bruce H.

SRPT T-6295.8, T-6316.4, T-6868.2, T-7071.1, T-7132.1 DT15-B 3M MEDICAL DEPARTMENT, CORPORATE TOXICOLOGY Title: Comparative Molecular Biology of Perfluorooctanesulfonate (PFOS, T-6295), N-ethyl perfluorooctanesulfonamido ethanol (N-EtFOSE, T-6316), N-Ethyl perfluorooctanesulfonamide (N-EtFOSA, T-6868), Perfluorooctanesulfonamido acetate (FOSAA, T-7071), and/or Perfluorooctanesulfonamide (FOSA, T-7132) of in Rats and Guinea Pigs following Oral dosing.

WATER SOLUBILITY (BY ANALYSIS OF TOC) TEST SUBSTANCE Identity: Perfluorooctanesulfonyl fluoride; may also be referred to as POSF, or FX-8. (1-Octanesulfonyl fluoride, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8-heptadecafluoro-, CAS #30735-7).

0 44t Repeat Application 28 Day Percutaneous Absorption Study with T-2618CoC in Albino Rabbits Experiment No.: Conducted At: Dates Conducted: Conducted By: 09790AB0485 Safety Evaluation Laboratory Riker Laboratories, Inc.

3M Dr.

RECEIVED OPPTNCIC 20084U6 -3 PH 2' 38 AR Z-Zb - 061S' f U\81uI,J\ *\<!

PFOS: A PILOT REPRODUCTION STUDY WITH THE MALLARD FINAL REPORT WILDLIFE INTERNATIONAL, LTD.

AR226-2022 "Roger J.